Paracetamol/ Ascorbic Acid/ Chlorphenamine
Indications
Registered South African indications:
- Symptomatic relief of runny nose, sneezing, sore throat, headache and generalised aching due to colds and flu
Boxed warning
| Paracetamol/ ascorbic acid/ chlorphenamine contains paracetamol which may be fatal in overdosage. In the event of overdosage or suspected overdose and notwithstanding the fact that the person may be asymptomatic, the nearest doctor, hospital or Poison Centre must be contacted immediately. |
Contraindications (ZA)
Registered South African contraindications
- Hypersensitivity to the active ingredient or any of the excipients in this combination product
- Severe liver function impairment
- Coronary disease and cardiovascular disease such as ischaemic heart disease, dysrhythmia, or tachycardia
- Epilepsy
- Children under the age of 12 years
- Prior sensitivity to any antihistamine
- Patients receiving monoamine oxidase inhibitor treatment, or within 14 days of stopping such treatment
- Patients undergoing anaesthesia with halothane or other halogenated anaesthetics, as they may induce ventricular fibrillation
- Pregnancy
- Lactation
Warnings & precautions
South African recommendations
- Renal impairment
- Mild to moderate hepatic impairment
- Elderly
May impair ability to drive and operate machinery
- May lead to drowsiness and impaired concentration that may be aggravated by the simultaneous intake of alcohol or other central nervous system depressants
- Patients should be advised, particularly at the initiation of therapy, against taking charge of vehicles or machinery or performing potentially hazardous tasks where loss of concentration could lead to accidents
Paracetamol
Excess doses
- Dosages in excess of those recommended may cause severe liver damage. Consult a medical practitioner if pain or fever persists or gets worse at the recommended dosage, if new symptoms occur or if redness and swelling is present, as these could be signs of a more serious condition
- Do not use this combination product continuously for more than 7 days without consulting your doctor
Liver disease
- Patients suffering from hepatitis or alcoholism, or recovering from any form of liver disease, should not take excessive quantities
Renal disease
- Use with caution in renal disease
Contains the sugar alcohol, sorbitol
- Patients with rare hereditary problems of fructose intolerance should not take this medicine
Chlorphenamine maleate
Caution in patients with:
- Prostatic hypertrophy
- Narrow-angle glaucoma
- Emphysema
- Chronic bronchitis
- Porphyria
- Pyloroduodenal obstruction
- Epilepsy
- Severe cardiovascular disorders
Children and elderly
- Paradoxical hyperexcitability, nervousness and insomnia may occur in children and in the elderly
- Elderly patients are especially susceptible to dizziness, sedation, confusion, hypotension and anticholinergic effects such as dry mouth and urinary retention
Drowsiness and impaired concentration
- May lead to drowsiness and impaired concentration that may be aggravated by the simultaneous intake of alcohol or other central nervous system depressants
- May enhance the sedative effects of CNS depressants including alcohol, barbiturates, hypnotics, opioid analgesics, anxiolytic sedatives and antipsychotics
Skin test results
- Chlorphenamine may suppress positive skin test results and should be stopped several days before the test
Sensitivity
- Patients sensitive to another antihistamine may be sensitive to this combination product
Adult dosage (ZA)
Forms avail. in SA and covered in this monograph: eft
South African registered indications and dosages
Symptomatic relief of runny nose, sneezing, sore throat, headache and generalised aching due to colds and flu
Paracetamol/ Ascorbic Acid/ Chlorphenamine
500/250/2 (mg)
- Oral (eft): 1 tab, 8hrly if needed; Treatment duration: Not more than 7 days without further consultation
Dissolve one tablet in a glass of water and drink immediately once the whole tablet has dissolved
Patient should seek medical advice if no relief is obtained from the recommended dosage
Recommended doses should not be exceeded
Missed dose: Patients should take a dose as soon as possible and then continue with the normal dose. Patients should not take a double dose to compensate for the missed dose
Paediatric dosage (ZA)
Paed. forms avail. in SA and covered in this monograph: eft
South African registered indications and dosages
Symptomatic relief of runny nose, sneezing, sore throat, headache and generalised aching due to colds and flu
Paracetamol/ Ascorbic Acid/ Chlorphenamine
500/250/2 (mg)
- Younger than 12 years: Contraindicated
- Older than 12 years: See adult dosage
Pregnancy & lactation
Pregnancy
South African recommendations
- Contraindicated
- Safety in pregnancy has not been established
Breastfeeding
South African recommendations
- Contraindicated
- Safety during lactation has not been established
Fertility
South African recommendations
- No information available
Renal impairment
South African recommendations
- Caution; no dose adjustment recommended
Hepatic impairment
South African recommendations
- Mild to moderate: Caution; no dose adjustment recommended
Patients suffering from hepatitis or alcoholism, or recovering from any form of liver disease, should not take excessive quantities of paracetamol/ ascorbic acid/ chlorphenamine, as dosages in excess of those recommended may cause severe liver damage - Severe: Contraindicated
Elderly
South African recommendations
- Caution; no dose adjustment recommended
Elderly patients are especially susceptible to dizziness, sedation, confusion, hypotension and anticholinergic effects such as dry mouth and urinary retention
Adverse reactions
Combination products may have additional pharmacological effects not accounted for by the action of the individual ingredients
Paracetamol
Blood and Lymphatic System Disorders
Less frequent
- Agranulocytosis
- Thrombocytopenia
- Leucopenia
- Pancytopenia
- Neutropenia
- Anaemia
Hepato-Biliary Disorders
Less frequent
- Hepatitis
Frequency unknown
- Pancreatitis
Skin and Subcutaneous Tissue Disorders
Less frequent
- Allergic dermatitis
Frequency unknown
- Dermatitis
Renal and Urinary Disorders
Less frequent
- Renal colic
- Renal failure
- Sterile pyuria
General Disorders and Administrative Site Conditions
Frequency unknown
- Dermatitis
- Skin rashes and other allergic reactions
- Rash types (erythematous or urticarial), which can be serious and accompanied by fever and mucosal lesions
Ascorbic Acid
Blood and Lymphatic System Disorders
Frequency unknown
- Haemolysis in patients with glucose-6-phosphate dehydrogenase deficiency due to large doses of ascorbic acid
Gastrointestinal Disorders
Less frequent
- Diarrhoea and other gastrointestinal disturbances from large doses
Renal and Urinary Disorders
Frequency unknown
- Hyperoxaluria and formation of renal calcium oxalate calculi from large doses
- Need for caution in patients with hyperoxaluria
- Tolerance development with prolonged use of large doses
Chlorphenamine maleate
Blood and Lymphatic System Disorders
Less frequent
- Blood dyscrasias
- Agranulocytosis
- Leukopenia
- Haemolytic anaemia
- Thrombocytopenia
Immune System Disorders
Less frequent
- Anaphylaxis (including tightness of the chest)
- Hypersensitivity reactions (including bronchospasm, angioedema)
Psychiatric Disorders
Frequency unknown
- Depression
Nervous System Disorders
Frequent
- Drowsiness
Less frequent
- Central nervous system reactions
- Sedation
- Seizures
- Dizziness
- Increased sweating
- Abnormal coordination
- Tremor
- Lassitude
- Euphoria
- Nervousness
- Insomnia
- Headache
Frequency unknown
- Confusion
- Hallucinations
- Paraesthesias
- Ataxia
Eye Disorders
Less frequent
- Blurred vision
- Diplopia
Ear and Labyrinth Disorders
Less frequent
- Tinnitus
Cardiac Disorders
Less frequent
- Hypotension
- Palpitations
- Dysrhythmia
- Tachycardia
Frequency unknown
- Hypertension
- Tightness of the chest
- Tingling
- Heaviness and weakness of the hands
Respiratory, Thoracic, and Mediastinal Disorders
Less frequent
- Thickening of mucous
Frequency unknown
- Dryness of the respiratory passages
Gastrointestinal Disorders
Frequent
- Dryness of mouth, nose, or throat
- Gastrointestinal upset
- Loss of appetite
- Constipation
- Diarrhoea
- Nausea
- Vomiting
Frequency unknown
- Epigastric pain
- Gastric reflux
Hepato-Biliary Disorders
Less frequent
- Cholestasis
- Hepatitis
- Other hepatic function abnormalities
Skin and Subcutaneous Tissue Disorders
Less frequent
- Exfoliative dermatitis
- Rashes
Frequency unknown
- Photosensitivity and skin rash
- Allergic dermatitis
- Drug fever
- Hair loss
- Sweating
Musculoskeletal, Connective Tissue and Bone Disorders
Frequency unknown
- Extrapyramidal effects (including muscle spasms and dystonia)
- Myalgia
Renal and Urinary Disorders
Less frequent
- Difficult or painful urination (dysuria)
Frequency unknown
- Urinary frequency
General Disorders and Administrative Site Conditions
Less frequent
- Oedema
- Fatigue
Interactions
Combination products may have additional pharmacological effects not accounted for by the action of the individual ingredients
Paracetamol/ Ascorbic Acid/ Chlorphenamine
- Central nervous system depressants
- Sedatives
- Tranquillizers
Paracetamol
- Hepatotoxic agents
- Enzyme inducing agents
- Metoclopramide
- Cholestyramine
- Salicylates
- Probenecid
Ascorbic acid
- Desferrioxamine
- Oral contraceptives
- Fluphenazine
- Warfarin
Chlorpheniramine
- Monoamine oxidase inhibitors
- Central nervous system depressants
- Barbiturates
- Hypnotics
- Opioid analgesics
- Anxiolytic sedatives
- Antipsychotics
- Belladonna
- Tricyclic antidepressants
- Maprotiline
- Guanethidine
- Reserpine
- Methyldopa
- Atropine
Other interactions
- Alcohol
Monitoring
None routine
Mechanism of action
Paracetamol/chlorphenamine maleate/ascorbic acid effervescent tablets have analgesic, antipyretic and antihistaminic properties.
Paracetamol
Paracetamol has analgesic and antipyretic effects.
Ascorbic acid
A vitamin supplement.
Chlorphenamine maleate
Chlorphenamine maleate is a reversible H1 receptor antagonist which inhibits the interaction of histamine with H1 receptors. H1 antagonists inhibit most of the effects of histamine on smooth muscles, especially the constriction of respiratory smooth muscle. H1 antagonists suppress histamine-evoked salivary lacrimal and other exocrine secretions.
Dosage forms
- Effervescent tablet
Formulation
COMBINATION PREPARATIONS
Paracetamol/ Ascorbic acid/ Chlorpheniramine
Tablet effervescent 500mg/250mg/2mg
- Efferflu-C Cold & Flu (Pharma Dynamics)
- Paragrip C (Pharma Dynamics)
References
1. PI - EFFERFLU C COLD & FLU Effervescent tablets, Pharma Dynamics (Pty) Ltd - DATE OF REVISION OF THE TEXT 31 May 2021 Downloaded online 16 Nov 2023 [https://medsinfoportal.sahpra.org.za/pi/ec215b8abf835a66f2a1431b58e01139.pdf] 2. NAPOS The Drug Database for Acute Porphyria: R06AB04 Chlorphenamine; Accessed online 10 Jan 2019 http://www.drugs-porphyria.org/languages/UnitedKingdom/s3.php?atc_code=R06AB04&l=gbr 3. South African Institute for Drug-Free Sport; Paragrip-C; Accessed online 10 Jan 2019 [http://www.drugfreesport.org.za/online-medication-check/]
Brands & products
10 products · cached snapshot- Chlorpheniramine maleate (syn.Chlorphenamine)Efferflu-C Cold & Flu
- Paragrip C
EFTEffervescent tablet · 10 products
from R54.06| Product | Strength | Pack | Applicant | Min price |
|---|---|---|---|---|
| Pachlofizz | 500 mg;mg;mg | 12 | Trinity Pharma (Pty) Ltd | R54.06 |
| Paragrip C | 500 mg;mg;mg | 12 | Unicorn Pharmaceuticals (Pty) Ltd | R57.16 |
| Rhinileve | 500 mg;mg;mg | 12 | Trinity Pharma (Pty) Ltd | R58.28 |
| Coryx Para C | 500 mg;mg;mg | 12 | Cipla Medpro (Pty) Ltd | R62.43 |
| Efferflu-C Cold & Flu | 500 mg;mg;mg | 12 | Pharma Dynamics (Pty) Ltd | R65.86 |
| Flulez | 500 mg;mg;mg | 20 | Trinity Pharma (Pty) Ltd | R91.18 |
| Paragrip C | 500 mg;mg;mg | 20 | Unicorn Pharmaceuticals (Pty) Ltd | R95.18 |
| Rhinileve | 500 mg;mg;mg | 20 | Trinity Pharma (Pty) Ltd | R97.18 |
| Coryx Para C | 500 mg;mg;mg | 20 | Cipla Medpro (Pty) Ltd | R104.05 |
| Efferflu C Cold & Flu | 500 mg;mg;mg | 20 | Pharma Dynamics (Pty) Ltd | R109.82 |
Medical aid coverage
data not yet integrated- Comprehensive Series—
- Executive Plan—
- KeyCare Series—
- Priority Series—
- Saver Series—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- BonClassic—
- BonComprehensive—
- BonEssential—
- BonFit Select—
- BonSave—
- BonStart—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- Beryl—
- Emerald—
- Onyx—
- Ruby—
- Sapphire—
- Tanzanite One—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- Aquarium Option—
- Efficiency Option—
- Marine Option—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.